Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 101.9 USD 0.75% Market Closed
Market Cap: 150.7B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one BSX stock under the Base Case scenario is 86.18 USD. Compared to the current market price of 101.9 USD, Boston Scientific Corp is Overvalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSX Relative Value
Base Case
86.18 USD
Overvaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.6
P/S
P/S
Price to Sales
8.6
vs History
3
vs Industry
14
Median 3Y
5.9
Median 5Y
5.5
Industry
2.2
Forward
7.8
More Details
73.9
P/E
P/E
Price to Earnings
73.9
vs History
38
vs Industry
5
Median 3Y
73.4
Median 5Y
68.7
Industry
21.8
Forward
35.2
More Details
43.8
P/OCF
P/OCF
Price to OCF
43.8
vs History
20
vs Industry
5
Median 3Y
42.2
Median 5Y
38
Industry
13.4
More Details
35.2
P/FCFE
P/FCFE
Price to FCFE
35.2
vs History
65
vs Industry
12
Median 3Y
56.4
Median 5Y
53.6
Industry
19
More Details
6.9
P/B
P/B
Price to Book Value
6.9
vs History
3
vs Industry
9
Median 3Y
4.3
Median 5Y
3.9
Industry
2.1
More Details
9
EV/S
EV/S
Enterprise Value to Sales
9
vs History
3
vs Industry
12
Median 3Y
6.5
Median 5Y
6.2
Industry
2.3
Forward
8.2
More Details
13.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.2
vs History
3
vs Industry
14
Median 3Y
9.3
Median 5Y
9.1
Industry
4.8
More Details
34.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
34.9
vs History
23
vs Industry
7
Median 3Y
25.1
Median 5Y
28.8
Industry
11.4
Forward
27
More Details
48.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
48.4
vs History
26
vs Industry
7
Median 3Y
37.9
Median 5Y
42
Industry
15.5
Forward
29.7
More Details
46.2
EV/OCF
EV/OCF
Enterprise Value to OCF
46.2
vs History
26
vs Industry
5
Median 3Y
45.8
Median 5Y
42.4
Industry
13.3
More Details
60.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
60.1
vs History
53
vs Industry
6
Median 3Y
64.3
Median 5Y
60.6
Industry
17.1
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
3
vs Industry
17
Median 3Y
2.7
Median 5Y
2.4
Industry
1.8
More Details

Multiples Across Competitors

BSX Competitors Multiples
Boston Scientific Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Boston Scientific Corp
NYSE:BSX
150.3B USD 8.6 73.9 34.9 48.4
US
Abbott Laboratories
NYSE:ABT
223.1B USD 5.3 16.5 21.5 30.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
108B USD 3.3 25.4 13.6 19.2
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.7B USD 9.2 40.2 28.6 31.9
US
Resmed Inc
NYSE:RMD
34.6B USD 6.9 26.4 18.8 21.3

See Also

Summary
BSX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSX stock valuation using valuation multiples.
Wall Street Estimates
BSX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.